Systematic Review and Meta-Analysis of the Efficacy of Sphingosine-1-Phosphate (S1P) Receptor Agonist FTY720 (Fingolimod) in Animal Models of Stroke

REFERENCES

• Singh IN, Hall ED. Multifaceted roles of sphingosine-1-phosphate: how does this bioactive sphingolipid fit with acute neurological injury? J Neurosci. 2008;86(7):1419–33.
   Google Scholar
• Brinkmann V, Michael MD, Heise CE, Albert R, Cottens S, Hof R, Bruns C, Prieshcl E, Baumruker T, Hiestand P, Foster CA, Zollienger M, Lynch KR. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem. 2002;277(24):21453–7.
   PubMed Web of Science ®Google Scholar
• Yagi H, Kamba R, Chiba K, Soga H, Yaguchi K, Nakamura M, Itoh T. Immunosuppressant FTY720 inhibits thymocyte emigration. Eur J Immunol. 2000;30(5):1435–44.
   PubMedGoogle Scholar
• Brinkmann V, Pinschewer DD, Feng L, Chen S. FTY720: altered lymphocyte traffic results in allograft protection. Transplantation. 2001;72(5):764–9.
   PubMedGoogle Scholar
• Jung CG, Kim HJ, Miron VE, Cook S, Kennedy TE, Foster CA, Antel JP, Soliven B. Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells. Glia. 2007;55(16):1656–67.
   PubMed Web of Science ®Google Scholar
• Wacker BK, Park TS, Gidday JM. Hypoxic preconditioning-induced cerebral ischemic tolerance role of microvascular sphingosine kinase 2. Stroke. 2009;40(10):3342–8.
   PubMed Web of Science ®Google Scholar
• Kappos L, Antel J, Comi G, Montalban X, O'Connor P, Polman CH, Haas T, Korn AA, Karlsson G, Radue EW. FTY720 D2201 study group, oral fingolimod FTY720 for relapsing multiple sclerosis. N. Engl J Med. 2006;355(11):1124–40.
   PubMed Web of Science ®Google Scholar
• Sandercock P, Roberts I. Systematic reviews of animal experiments. Lancet. 2002;360(9333):586.
   PubMedGoogle Scholar
• Macleod M, Sandercock P. Can systematic reviews help animal experimental work? RDS News winter 2005.
   Google Scholar
• Egger M, Smith GD, Altman D. Systematic reviews in health care: meta-analysis in context. London: BMJ Books, 2001.
   Google Scholar
• Macleod MR, O'Collins T, Howells DW, Donnan GA. Pooling of animal experimental data reveals influence of study design and publication bias. Stroke, 2004, 35(5):1203–8.
   PubMed Web of Science ®Google Scholar
• Macleod MR, Vander Worp HB, Sena ES, Howells DW, Dirnagl U, Donnan GA. Evidence for the efficacy of NXY-059 in experimental focal cerebral ischemia is confounded by study quality. Stroke. 2008;39(10):2824–9.
   PubMedGoogle Scholar
• Minnerup J, Heidrich J, Wellmann J, Rogalewski A, Schneider A, Schabitz WR. Meta-analysis of the efficacy of granulocyte-colony stimulating factor in animal models of focal cerebral ischemia. Stroke. 2008;39(6):1855–61.
   PubMed Web of Science ®Google Scholar
• Frantzias J, Sena ES, Macleod MR, Salman AR. Treatment of intra cerebral hemorrhage in animal models: meta-analysis Ann Neurol. 2011;69(2):389–99.
   PubMedGoogle Scholar
• Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, Lo EH, STAIR Group. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke. 2009;40(6):2244–50.
   PubMed Web of Science ®Google Scholar
• Liesz A, Sun L, Zhou W, Schwarting S, Mracsko E, Zorn M, Bauer H, Sommer C, Veltkamp R. FTY720 reduces post-ischemic brain lymphocyte influx but does not improve outcome in permanent murine cerebral ischemia. PLoS ONE. June 2011; 6(6):e21312. DOI:10.1371/journal.pone.0021312.
   PubMed Web of Science ®Google Scholar
• Wei S, Su ZQ, Song L, Wang B, Yao M. Expression of S1P1 in focal brain ischemia-reperfusion rat. JA Poplexy and Nervous Diseases. 2011;28(2):347–51.
   Google Scholar
• Hasegawa Y, Suzuki H, Sozen T, Rolland W, Zhang JH. Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. Stroke. 2010;41(2):368–74.
   PubMed Web of Science ®Google Scholar
• Wei Y, Yemisci M, Kimm HH, Yung LM, Shin HK, Hwang SK, Guo S, Qin T, Alsharif N, Brinkmann V, Liao JK, Lo EH, Waeber C. Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann Neurol. 2010;69(1):119–29.
   PubMedGoogle Scholar
• Shichita T, Sugiyama Y, Ooboshi H, Sugimori H, Nakagawa R, Takada I, Iwaki T, Okada Y, Lida M, Cua DJ, Iwakura Y, Yoshimura A. Pivotal role of cerebral interleukin-17–producing T cells in the delayed phase of ischemic brain injury. Nat Med. 2009;15(8):946–50.
   PubMed Web of Science ®Google Scholar
• Czech B, Pfeilschifter W, Mazaheri-Omrani N, Strobel MA, Kahles T, Neumann-Haefelin T, Rami A, Huwiler A, Pfeilschifter J. The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia. Biochem Biophys Res Commun. 2009;389(2): 251–6.
   PubMed Web of Science ®Google Scholar
• Pfeilschifter W, Czech-Zechmeister B, Sujak M, Foerch C, Wichelhaus TA, Pfeilschifter J. Treatment with the immunomodulator FTY720 does not promote spontaneous bacterial infections after experimental stroke in mice. Exp Transl Stroke Med. 2011;3(2):2040–2046.
   Google Scholar
• Pfeilschifter W, Czech-Zechmeister B, Sujak M, Mirceska A, Koch A, Rami A, Steinmetz H, Foerch C, Huwiler A, Pfeilschifter J. Activation of sphingosine kinase 2 is an endogenous protective mechanism in cerebral ischemia. Biochem Biophys Res Commun. 2011;413(2):212–7.
   PubMedGoogle Scholar
• Van der Worp HB, Sena ES, Donnan GA, Howells DW, Macleod MR. Hypothermia in animal models of acute ischemic stroke: a systematic review and meta-analysis. Brain. 2007;130(12):3063–74.
   PubMedGoogle Scholar
• Andaluz N, Zuccarello M, Wagner KR. Experimental animal models of intracerebral hemorrhage. Neurosurg Clin NAm. 2002;13(3):385–93.
   PubMed Web of Science ®Google Scholar
• Al-Shahi SR, Labovitz DL, Stapf C. Spontaneous intracerebral hemorrhage. BMJ. 2009;339:b2586.
   Google Scholar